Arhalofenate Completed Phase 2 Trials for Hyperuricemia / Gout Flares Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02252835Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
NCT01416402Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
NCT01336686Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout